Later today, a committee of advisors to the Food and Drug Administration will vote on whether or not the agency should approve flibanserin – the much-hyped yet controversial “female Viagra.” However, the drug has already been rejected twice previously by the organization, who cite safety concerns. In the wake of those decisions, battle lines have been drawn between:
- those who feel the agency is discriminating against the sexual health of women
- and those who feel the language of sexual equality has been hijacked in an attempt to force an ineffective and unsafe drug on the market.
MedicalNewsToday took a look at both sides of this dramatic debate…
- Will ‘the female Viagra’ really help women?, MedicalNewsToday, 4 June 2015.
- Pink Viagra may be coming soon (but for teetotalers, only!), healthnewsreview,
- Concerns remain for “Viagra for women” twice rejected by FDA, denverpost, 06/03/2015.
- Will Female Viagra Be An FDA Boner?, Science 2.0, May 28th 2015.
- ‘Viagra for Women’ Gets Push for F.D.A. Approval, The New York Times, MAY 31, 2015.